WW International, Inc. Common Stock
$ 27.72
-7.97%
26 Dec - close price
- Market Cap 276,838,000 USD
- Current Price $ 27.72
- High / Low $ 30.11 / 27.34
- Stock P/E 2.05
- Book Value 32.34
- EPS 13.55
- Next Earning Report 2026-02-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.09 %
- ROE N/A %
- 52 Week High 46.95
- 52 Week Low 20.53
About
WW International, Inc. is a leading innovator in the weight management and wellness sector, committed to empowering individuals in their health journeys through a unique blend of digital solutions and in-person support. Based in New York City, the company leverages its strong brand recognition and a science-backed approach to foster community engagement and drive sustainable health behaviors. With the ongoing expansion of the wellness market, WW's holistic strategies position it favorably for growth, making it an attractive opportunity for institutional investors looking to tap into evolving trends in health and nutrition.
Analyst Target Price
$47.33
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-11 | 2025-04-30 | 2025-02-27 | 2024-11-06 | 2024-08-01 | 2024-05-02 | 2024-02-28 | 2023-11-02 | 2023-08-03 | 2023-05-04 | 2023-03-06 |
| Reported EPS | -117.84 | 15.57 | -0.91 | 0.32 | 0.24 | 0.32 | -0.06 | -0.06 | 0.48 | 0.65 | -1.68 | -0.46 |
| Estimated EPS | 0.12 | 0.05 | -0.23 | -0.01 | 0.06 | 0.01 | -0.43 | -0.11 | 0.12 | 0.1 | -0.5 | 0.01 |
| Surprise | -117.96 | 15.52 | -0.68 | 0.33 | 0.18 | 0.31 | 0.37 | 0.05 | 0.36 | 0.55 | -1.18 | -0.47 |
| Surprise Percentage | -98300% | 31040% | -295.6522% | 3300% | 300% | 3100% | 86.0465% | 45.4545% | 300% | 550% | -236% | -4700% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-05 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.94 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: WW
2025-12-26 14:09:19
WW International is highlighting the success story of JoJo, who lost 40 pounds in seven months postpartum using their program. This initiative aims to inspire individuals, whether postpartum or not, to adopt healthier habits. The company uses such testimonials to demonstrate its commitment to promoting diverse paths to improved health and well-being.
2025-12-20 08:09:46
Shares of WW International (NASDAQ:WW) have risen above their 200-day moving average, trading at $27.54 with a 5% increase during Friday's session. Despite this upward movement, analyst ratings remain weak, with a consensus of "Reduce" and the company missing Q3 EPS estimates. Institutional ownership in WW International is notably high at 86.18%, with several firms increasing their positions in Q3.
2025-12-19 00:08:40
The chairman of Weight Watchers has joined the board of US bulker operator Pangaea Logistics Solutions, marking the second change in board representation for Strategic Shipping this month. This move comes as Christina Tan resigns from her position.
2025-12-17 16:08:39
Weight Watchers has launched a new, fully integrated platform designed for the GLP-1 era, combining GLP-1 prescribing through Weight Watchers Med+ with personalized nutrition, behavioral support, coaching, and a redesigned app experience. The platform also introduces the "GLP-1 Success Program" for comprehensive lifestyle support, a new "Weight Health Score," and an AI Body Scanner to track progress beyond just weight. This initiative aims to provide enhanced, holistic support for members managing their weight, especially those using GLP-1 medications.
2025-12-17 15:09:15
WeightWatchers has refreshed its brand identity and digital offerings, including a new logo, typography, and an AI-powered body scanner, to better integrate into the growing GLP-1 weight-loss drug market. The company also launched a dedicated GLP-1 medical program called WeightWatchers Med+ to provide tailored support for members using these medications. This overhaul aims to modernize WeightWatchers' approach and capitalize on the forecasted $150 billion GLP-1 market by 2030, following the company's recent bankruptcy protection filing.
2025-12-16 16:08:40
Weight Watchers (WW) International has launched a new, fully integrated platform designed to support individuals using GLP-1 medications for weight loss, alongside personalized nutrition, behavioral support, coaching, and community features. This new offering, called GLP-1 Success, aims to provide comprehensive support for managing GLP-1 side effects, preserving muscle mass, and achieving sustainable results. The platform also introduces a reimagined digital experience with a "Weight Health Score," an AI-powered body scanner, exclusive fitness content, and flexible "Modes" to adapt to members' evolving needs, all under a refreshed brand identity.
